tuftsin has been researched along with Inflammatory Bowel Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barshak, I; Bashi, T; Ben-Ami Shor, D; Bizzaro, G; Blank, M; Fridkin, M; Lachnish, J; Shoenfeld, Y | 1 |
1 other study(ies) available for tuftsin and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease.
Topics: Animals; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Phosphorylcholine; Severity of Illness Index; Tuftsin | 2015 |